Sie sind auf Seite 1von 23

OBJECTIVES

• DEFINITION OF PNEUMONIA
• TO REVIEW THE ETIOLOGY AND PATHOGENESIS OF PNEUMONIA
• TO KNOW THE DIASNOSTIC AIDS THAT ARE INITIALLY REQUESTED
• TO KNOW THE TREATMENT TO USE WITH REGARDS TO THE ETIOLOGIC AGENT
• HOW CAN A PNEUMONIA BE PREVENTED
PNEUMONIA
• IS THE INFLAMMATION OF THE PARENCHYMA OF THE LUNGS
• MOST CASES OF PNEUMONIA ARE CAUSED BY MICROORGANISM
• IS A SUBSTANTIAL CAUSE OF MORBIDITY AND MORTALITY IN CHILDHOOD THROUGHOUT THE WORLD.
• LEADING CAUSE OF DEATH GLOBALLY AMONG CHILDREN YOUNGER THAN 5 YEARS OLD
• IN DEVELOPING COUNTRIES, THE INTRODUCTION OF MEASLES VACCINE HAS GREATLY REDUCED THE
INCIDENCE OF MEASLES-RELATED PNEUMONIA DEATHS.
• NON INFECTIOUS CAUSES – ASPIRATION OF FOOD OR GASTRIC ACID; FOREIGN BODIES; HYDROCARBONS;
LIPID SUBSTANCES; HYPERSENSITIVITY REACTIONS AND DRUG OR RADIATION INDUCED PNEUMONITIS
SPECIFIC RISK FACTORS:
• LUNG DISEASE
• ANATOMIC PROBLEMS
• GASTROESOPHAGEAL REFLUX DISEASE WITH ASPIRATION
• NEUROLOGIC DISORDERS THAT INTERFERE WITH PROTECTION OF THE AIRWAY OR COMPROMISE
CLEARING OF THE AIRWAY
• DISEASES THAT ALTER THE IMMUNE SYSTEM, SUCH AS UMMUNODEFICIENCY DISEASES OR
HEMOGLOBINOPATHIES
ETIOLOGY
• MOST INFECTIOUS CASES ARE CAUSED BY FOLLOWING
• BACTERIAL: S. PNEUMONIA, GROUP B STREP, M. PNEUMONIAE, CHLAMYDOPHILA PNEUMONIA AND
CHLAMYDIA TRACHOMATIS
• VIRAL: RESPIRATORY SYNCYTIAL VIRUS, PARAINFLUENZA VIRUS 1-3, INFLUENZA A&B, ADENOVIRUS AND
HUMAN METAPNEUMOVIRUS

• VIRAL : PEAK ATTACK IS BETWEEN 2-3 YEARS OLD


• S. PNEUMONIA, M. PNEUMONIAE : OLDER THAN 5 YEARS OLD
CLINICAL MANIFESTATIONS
• URTI (COUGH, RHINITIS) • LETHARGY
• FEVER (BACTERIA CAUSE HIGH FEVER THAN VIRUS) • DIMINISHED APPETITE
• TACHYPNEA • ABDOMINAL PAIN
• INCREASE CYANOSIS AND FATIGUE IN INFANTS • LIVER MAY SEEM ENLARGED
• ADULTS AND OLDER CHILDREN TYPICALLY BEGINS • CRACKLES AND WHEEZING
SUDDENLY WITH A SHAKING CHILL FOLLOWED BY A
HIGH FEVER, COUGH , AND CHEST PAIN
• TACHYPNEA IS THE MOST CONSISTENT CLINICAL MANIFESTATION
• INCREASED WORKING BREATHING ACCOMPANIED BY INTERCOSTAL RETRACTIONS, NASAL FLARING AND
USE ACCESSORY MUSCLES
PREDICTORS OF CAP IN PATIENT WITH
COUGH

• AGES 3-5 : TACHYPNEA AND OR CHEST INDRAWING


• AGES 5-12 : FEVER, TACHYPNEA AND CRACKLES
• >12 : FEVER, TACHYPNEA, TACHYCARDIA ATLEAST 1 ABNORMAL CHEST FINDINGS RHONCHI, CRACKLES,
WHEEZES, DECREASE BREATH SOUNDS
• THE LOWER RESPIRATORY TRACT IS NORMALLY KEPT STERILE BY PHYSIOLOGIC DEFENSE MECHANISM,
INCLUDING MUCOCILIARY CLEARANCE.
• THE SECRETORY IMMUNOGLOBULIN A, AND CLEARING THE AIRWAY BY COUGHING
• IMMUNOLOGIC DEFENSE MECHANISMS OF THE LUNG THAT LIMIT INVASION BY PATHOGENIC ORGANISMS
INCLUDE MACROPHAGES THAT ARE PRESENT IN ALVEOLI AND BRONCHIOLES.
WHO SHALL BE CONSIDERED AS HAVING
COMMUNITY

ACQUIRED PNEUMONIA?
1. THE PRESENCE OF PNEUMONIA MAY BE CONSIDERED EVEN WITHOUT A CHEST RADIOGRAPH IN A PATIENT
PRESENTING WITH COUGH AND/OR RESPIRATORY DIFFICULTY THE FOLLOWING PREDICTORS OF RADIOGRAPHIC
PNEUMONIA:
• AT THE EMERGENCY ROOM AS THE SITE OF CARE:
• TACHYPNEA IN A PATIENT AGED 3MONTHS TO 5 YEARS
• FEVER AT ANY AGE
• OXYGEN SATURATION LESS THAN OR EQUAL TO 92% AT ROOM AIR AT ANY AGE ABSENCE OF ANY CO-EXISITING ILLNESS.

• AT THE OUT PATIENT CLINIC AS THE SITE OF CARE


• TACHYPNEA IN A PATIEN AGED 3MONTHS TO 5 YEARS
• FEVER AT ANY AGE
• 2. THE PRESENCE OF PNEUMONIA SHOULD BE DETERMINED USING A CHEST RADIOGRAPH IN A PATIENT
PRESENTING WITH
• COUGH AND/OR RESPIRATORY DIFFICULTY IN THE FOLLOWING SITUATIONS:
• PRESENCE OF DEHYDRATION AGED 3 MONTHS TO 5 YEARS
• PRESENCE OF SEVERE MALNUTRITION AGED LESS THAN 7 YEARS

• HIGH GRADE FEVER AND LEUKOCYTOSIS AGED 3-24 MONTHS WITHOUT RESIPIRATORY SYMPTOMS
WHO WILL REQUIRE ADMISSION?
PARAMETERS TO BE EVALUATED WHEN
CONSIDERING ADMISSION:
• 1. HOST FACTORS: • 2. EXTERNAL FACTORS:
• ABILITY TO FEED • A COMPLIANT CAREGIVER

• AGE • ABILITY TO FOLLOW UP

• SIGNS OF RESPIRATORY FAILURE


• PULMONARY COMPLICATIONS
• RESPIRATORY RATE
• STATE OF DEHYDRATION
• PRESENCE OF COMORBID FACTORS
• GRUNTING AND APNEA
• ARE MANIFESTATIONS OF ACUTE RESPIRATORY FAILURE REQUIRING ADMISSION TO CRICITICAL CARE UNIT
• CYANOSIS AND HEAD BOBBING
• INABILITY TO CRY, HEAD NODDING AND A RESPIRATORY RATE OF >60/MIN WERE BEST PREDICTORS OF
HYPOXEMIA
WHAT DIASNOSTIC AIDS INITIALLY
REQUESTED?
• PCAP - A & PCAP-B • PCAP C & D:
• NO DIASNOSTIC AIDS ARE INITIALLY REQUESTED • CHEST X RAY – PA LATERAL
• WHO IS BEING MANAGED IN AN AMBULATORY • WBC COUNT
SETTING • CULTURE AND SENSITIVITY OF
• BLOOD, PLEURAL FLUID, SPUTUM
ANTIBIOTIC RECOMMENDATION
• 1. FOR PATIENT CLASSIFIED AS EITHER PCAP-A OR B IS
• BEYOND 2 YEARS OF AGE
• HAVING HIGH FEVER WITHOUT WHEEZE
• 2. FOR A PATIENT CLASSIFIED AS PCAP-C AND IS
• BEYOND 2 YEARS OF AGE
• HAVING A HIGH GRADE WITHOUT WHEEZE
• HAVING ALVEOLAR CONSOLIDATION IN CXR
• WBC COUNT >15,000
WHAT EMPIRIC TREATMENT SHOULD BE
CONSIDERED IF A BACTERIAL ETIOLOGY IS
CONSIDERED?
• FOR A PATIENT WHO HAS BEEN CLASSIFIED AS PCAP-A OR B WITHOUT PREVIOUS ANTIBIOTIC
• AMOXICILLIN IS THE DRUG OF CHOICE
• AZITHROMYCIN
• CLARITHROMYCIN : GIVEN TO THOSE PATIENTS WITH KNOWN HYPERSENSITIVITY TO AMOXICILLIN
• FOR PCAP-C WITHOUT PREVIOUS ANTIBIOTIC, REQUIRING HOSPITALIZATION
• A. HAS COMPLETED THE PRIMARY IMMUNIZATION AGAINST H.INFLUENZA TYPE B, PENICILLIN G,
ADMINISTERED AS MONOTHERAPY IS THE DRUG OF CHOICE
• B. HAS NOT COMPLETED THE PRIMARY IMMUNIZATION OF IMMUNIZATION STATUS UNKNOWN AGAINST H.
INFLUENZA TYPE B, AMPICILLIN IS THE DRUG OF CHOICE.
WHAT TREATMENT SHOULD BE INITIALLY
GIVEN IF A VIRAL ETIOLOGY IS
CONSIDERED?
• 1. OSELTAMIVIR: THE DRUG OF CHOICE FOR LABORATORY CONFIRMED OR CLINICALLY SUSPECTED CASES
OF INFLUENZA.
A PATIENT BE CONSIDERED AS RESPONDING
TO THE CURRENT ANTIBIOTIC WHEN
• DECREASE IN RESPIRATORY SIGNS AND OR DEFERVESCENSE WITHIN 72 HOURS AFTER INITIATION OF
ANTIBIOTIC
• IF AN INPATIENT CLASSIFIED AS PCAP C IS NOT RESPONDING TO THE CURRENT ANTIBIOTIC WITHIN 72
HOURS CONSIDER ANY OF THE FOLLOWING:
• CO EXISTING ILLNESS
• CONDITIONS SIMULATING PNEUMONIA
HOW CAN PNEUMONIA BE PREVENTED?
• VACCINE AGAINST:
• 1. STREPTOCOCCUS PNEUMONIA
• INFLUENZA
• DIPHTHERIA, PERTUSSIS, RUBEOLA, VARICELLA, HAEMOPHILUS INFLUENZA TYPE B
• MICRONUTRIENT
• ELEMENTAL ZINC FOR AGES 2-59 MONTHS TO BE GIVEN FOR 4-6 MONTHS
• VITAMIN D3 SUPPLEMENTATION
• VITAMIN A SHOULD NOT BE GIVEN TO PREVENT PNEUMONIA
THANK YOU.!

Das könnte Ihnen auch gefallen